PATENT CLAIM ANALYSIS

Application Number: 15756798
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["536", "023100"]

Abstract:
The invention relates to a combination and its use for the treatment of diseases. The instant disclosure provides a combination of a so-called T-cell regulator selected from the group comprising PD1, PD-L1, OX40, TIM-3, LAG3, CD137(4-1BB) and a non-coding immunomodulating DNA.

Claim (Index 23):
A linear open-chained non-coding sequence of deoxyribonucleic acids selected from the group comprising the core sequences [yTCATTxCGTGACGTGACGTTCzv] and [yTCATTxTCGTCGTTTTGTCGTTTTGTCGzv], wherein y=2 to 8 G, protected with 1 to 3 L-deoxyriboses or not; x=3 to 4 A; z=2 to 6 T protected with 1 to 3 L-deoxyriboses and v=A, G, C or T, preferably selected from the group comprising SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9 and SEQ ID NO: 11, even more preferably selected from the group comprising SEQ ID NO: 7 and SEQ ID NO: 11.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 1.34211
- Patent Class: 536.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['10057311', '14046044', '12442295', '11549048', '11743876']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6261583674082152
- 35 USC 102 Novelty (BERT): 0.5097602136385432
- Combined Prediction Score: 0.6145185520312479
- Mean Citation Score: 284.0886240000001
- Max Citation Score: 291.83954
- Similarity Product: 191.00743300226088

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test